CDK activity antagonizes Whi5, an inhibitor of G1/S transcription in yeast

Michael Costanzo1, Joy L Nishikawa, Xiaojing Tang

  • 1Department of Medical Genetics and Microbiology, University of Toronto, 1 King's College Circle, Toronto, M5S 1A8, Canada.

Cell
|June 24, 2004
PubMed

Insights

Cyclin-dependent kinase (CDK) activity controls cell division. In yeast, Whi5 protein inhibits G1/S transcription until CDK phosphorylation releases this block, harmonizing cell cycle control across eukaryotes.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Cyclin-dependent kinase (CDK) activity drives the eukaryotic cell cycle, initiating gene expression in late G1.
  • In metazoans, CDK-phosphorylated retinoblastoma protein (Rb) activates G1/S transcription by releasing E2F.
  • A direct G1 phase target for CDK activity in yeast has been elusive.

Purpose of the Study:

  • To identify the elusive G1/S transcription regulator in yeast.
  • To elucidate the mechanism by which CDK activity controls G1/S transcription in yeast.
  • To harmonize the understanding of G1/S cell cycle control across eukaryotes.

Main Methods:

  • Investigated the role of Whi5 in G1/S transcription.
  • Utilized gene deletion and CDK activity manipulation in yeast.
  • Employed in vivo and in vitro biochemical assays to study protein interactions and localization.

Main Results:

  • Identified Whi5 as a cell size regulator that inhibits G1/S transcription.
  • Demonstrated that CDK-mediated phosphorylation dissociates Whi5 from SBF/MBF transcription factors, releasing G1/S repression.
  • Showed that Whi5 deletion accelerates the G1/S transition by bypassing upstream activators.
  • Observed Whi5 nuclear import/export regulated by CDK activity, linking cell cycle progression to transcriptional repression.

Conclusions:

  • Whi5 acts as a crucial inhibitor of G1/S transcription in yeast.
  • CDK-dependent phosphorylation and subsequent nuclear export of Whi5 are key events relieving G1/S repression.
  • These findings establish a conserved mechanism for G1/S cell cycle control in eukaryotes, analogous to Rb function in metazoans.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...